Friday, June 23, 2017

Is The Eurozone's 'Recent' Underperformance Something to Sweat?

While our core Eurozone ETF (FEZ) has produced a substantially higher year-to-date return versus the U.S. market (5.9% better as of this morning), the past few weeks have been an altogether different story (FEZ was better by a whopping 11.4% on 5/19).

Click to enlarge...



Thursday, June 22, 2017

Stat of the Day: Abnormal Volatility

While the headlines have indeed been volatile thus far in 2017, the U.S. stock market has been anything but. The S&P 500's largest drawdown year-to-date has been a measly 2.8%! While applying that percentage to the Dow would be -600+ points, in the historic scheme of things, make no mistake, that's measly!

Wednesday, June 21, 2017

This Week's Message: Eeyore Would Be a Star!

In two recent blog posts I touched on the seemingly popular notion that a market at all-time highs is doomed to collapse under the weight of its all-time-highness, and on the dire prognostications of a gentleman who -- despite his dismal track record -- receives a visionary's welcome by the mainstream financial media.

As regular readers/viewers know, we prefer to let the somewhat slow-moving, generally boring and often redundant data do the talking. No wonder CNBC never calls us for an interview!

Tuesday, June 20, 2017

Charts of the Day: Embracing (as an investor) Globalization!

In my June 3rd blog post I suggested that Western investors would be ill-advised to ignore China's Belt and Road Initiative.

Monday, June 19, 2017

Quotes of the Day: Stockman Strikes Again -- Or, Perhaps -- Stockman Strikes Out Again (time will tell)

David Stockman -- a man who has leveraged his tenure with the Reagan administration to the absolute hilt -- has a warning for all investors:
"This is one of the most dangerous market environments we've ever been in. It's the calm before a gigantic, horrendous storm that I don't think is too far down the road."

Friday, June 16, 2017

Chart of the Day: Financial Sector Breadth

The financial sector -- our presently highest target weighting -- seems to be finding its legs.